Copaxone repairs nerve tissue in multiple sclerosis patients
Teva reported the results of a 12-month MRI study on the evolution of multiple sclerosis lesions. View post: Copaxone repairs nerve tissue in multiple sclerosis patients Continue Reading
Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with …
Researchers utilizing an advanced magnetic resonance imaging technology to characterize and chart the evolution of MS lesions found that relapsing-remitting multiple sclerosis patients treated with Continue Reading
Multiple Sclerosis May Cause Changes in Thalamus: Study
FRIDAY, Dec. Read the original post: Multiple Sclerosis May Cause Changes in Thalamus: Study Continue Reading
Experimental multiple sclerosis drug shows promise
Phase III trials show a drug appears to slow progression of multiple sclerosis and has significantly better results than an effective drug already on the market, Oklahoma Medical Research Continue Reading
Multiple sclerosis linked to different area of brain
Radiology researchers have found evidence that multiple sclerosis affects an area of the brain that controls cognitive, sensory and motor functioning apart from the disabling damage caused by the Continue Reading
MorphoSys Initiates Phase 1b Clinical Trial with MOR103 in Patients with Multiple Sclerosis
MARTINSRIED, GERMANY and MUNCHEN, GERMANY-- - MorphoSys AG /MorphoSys Initiates Phase 1b Clinical Trial with MOR103 in Patients withMultiple SclerosisProcessed and transmitted by Thomson Reuters Continue Reading
Breakthrough Multiple Sclerosis Treatment? – Video
A new drug could help treat the debilitating symptoms of early stage multiple sclerosis, according to latest research released on Thursday. (Oct Go here to read the rest: Breakthrough Multiple Continue Reading
New MRI method can track progression of multiple sclerosis
Medical researchers at the University of Alberta have discovered a new way to track the progression of multiple sclerosis (MS) in those living with the disease, by using a powerful, triple strength Continue Reading
When MS Attacks: Fighting Flare-ups of Multiple Sclerosis
Here's the latest on fighting flare-ups of multiple sclerosis. More: When MS Attacks: Fighting Flare-ups of Multiple Sclerosis Continue Reading
Copaxone competitor investigating MS patient’s death
A US multiple sclerosis patient died after taking Novartis's oral treatment Gilenya, an alternative to Teva's Copaxone. See the original post here: Copaxone competitor investigating MS patient's Continue Reading
Gene links vitamin D and multiple sclerosis
A rare genetic variant which causes reduced levels of vitamin D appears to be directly linked to multiple sclerosis (MS), says an Oxford University study. Read the original post: Gene links Continue Reading
Fundraiser planned for man with Multiple Sclerosis
A fundraiser is set for Saturday for Steve Sloan, who has multiple sclerosis. See the article here: Fundraiser planned for man with Multiple Sclerosis Continue Reading
Dr. Paul Donohue: Multiple sclerosis can often relapse, remit
Dear Dr. Donohue: My granddaughter was recently diagnosed with multiple sclerosis. She soon will be 45 Read more: Dr. Paul Donohue: Multiple sclerosis can often relapse, remit Continue Reading
Novartis Pill for Multiple Sclerosis Rejected by U.K. Health-Cost Agency
Novartis AG’s (NOVN) multiple sclerosis pill Gilenya failed for a second time to gain the backing of the U.K.’s health-cost agency, denting the company’s ambitions to turn the drug into a Continue Reading
Multiple Sclerosis – Myelin Repair – Video
An exploration of the role of myelin repair in the treatment of multiple sclerosis. Read more: Multiple Sclerosis - Myelin Repair - Video Continue Reading
Multiple sclerosis group lauds health care program
IRVINE — After a thorough review, the National Multiple Sclerosis Society has recognized UC Irvine Healthcare's multiple sclerosis program for superior and innovative patient care by certifying it Continue Reading
Research and Markets: Multiple Sclerosis – Pipeline Review, H2 2011
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/719630/multiple_sclerosis) has announced the addition of Global Markets Direct's new report "Multiple Continue Reading
Progressive MS study gains $3.8M grant
Canadian researchers investigating the role of inflammation in multiple sclerosis will receive a $3.8 million grant towards their efforts. Go here to read the rest: Progressive MS study gains $3.8M Continue Reading
New MS research to look for clues to interplay between disease, inflammation
TORONTO - A group of Canadian researchers has received funding to try to figure out what role inflammation plays in progressive multiple sclerosis. See the original post: New MS research to look Continue Reading
MS Society of Canada Announces $3.8 Million to Study Progressive Forms of Multiple Sclerosis
TORONTO, ONTARIO-- - The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced a $3.8 million grant to investigate the complex interplay between Continue Reading
